Evidence map›Paper›PMID 40826488›Full record

ArticleJournal of health, population, and nutrition2025

Evolving landscape of hepatitis C research in the Eastern Mediterranean Region: A comprehensive bibliometric analysis from 2004 to 2024.

Kamiar Izadpanah, Seyed Aria Nejadghaderi, Hamid Sharifi

Abstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kamiar IzadpanahHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Seyed Aria NejadghaderiHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Hamid SharifiHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. sharifihami@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis C presents a significant public health challenge in the Eastern Mediterranean Region (EMR), which has the highest global disease burden. This study aims to provide a comprehensive overview of Hepatitis C-related research in the EMR using bibliometric analysis.

methodsBetween January 1, 2004, and December 31, 2024, a bibliometric search was conducted using the Scopus database to identify Hepatitis C-related publications from countries in the EMR. The analysis was performed using the R-based Bibliometrix tool, which examined research productivity trends, recent themes, thematic evolution, and co-occurrence networks of terms.

resultsThe analysis identified 9,357 publications with an 8.06% annual growth rate and 170,021 total citations. Two distinct research clusters emerged: treatment regimens and epidemiological studies. Thematic evolution revealed a consistent focus on cirrhosis and hepatocellular carcinoma, while treatment approaches shifted from interferon-based therapies to direct-acting antivirals. Analysis of genotype-related research highlighted the regional importance of Genotype 4. Recent trends indicated integrating Hepatitis C research with broader public health concerns like COVID-19.

conclusionsThe Hepatitis C research landscape in the EMR is dynamic and maturing, characterized by substantial growth, diversification of research themes, and adoption of advanced treatment strategies. The findings underscore the need for continued multidisciplinary efforts and a focus on emerging themes to advance Hepatitis C management further and improve regional patient outcomes.

Indexed as

BibliometricsBiomedical ResearchHepatitis CAntiviral AgentsCOVID-19HepacivirusHumansMediterranean RegionAntiviral AgentsBibliometric analysisEastern Mediterranean RegionHepatitis CLiver cirrhosisLiver neoplasmsPublic health

Identifiers

PMID40826488
PMCPMC12363047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.